Literature DB >> 8776670

Neurotrophin activates signal transduction in oligodendroglial cells: expression of functional TrkC receptor isoforms.

S Kumar1, J de Vellis.   

Abstract

The role of the NT-3 has been implicated in the survival of progenitor oligodendrocytes in culture. The object of this study was to investigate the expression of the TrkC receptor and its responsiveness in glial cells. We report the expression of two TrkC receptor isoforms in rat primary oligodendrocyte cultures, a glial progenitor cell line, CG-4, and in C6 glioma cells. The reverse transcription-polymerase chain reaction-aided amplification of glial trkC with specific primers from the kinase domain, followed by its cloning and sequencing, shows the presence of two trkC transcripts. The sequence of one of the transcripts is homologous to a previously identified trkC isoform which encodes a functional receptor. The other transcript contains a 42-bp insert in the kinase domain. A Western blot of CG-4 and C6 probed with antibody to a TrkC revealed the presence of gp145-kDa protein band. The investigations revealed a rapid autophosphorylation of gp145TrkC in CG-4 and C6 cells in the presence of its specific ligand, NT-3. Furthermore, K252a, a neurotrophin-specific inhibitor, abolishes the NT-3-mediated receptor autophosphorylation. We also examined other NT-3-dependent phosphorylation of cellular substrates in oligodendroglial cells. Interestingly, we observed phosphorylation of phospholipase C gamma-1 in CG-4 and C6 cells, and phosphorylation of phosphatidylinositol 3-kinase in C6 cells in the presence of NT-3. Both the NT-mediated phosphorylation of phospholipase C gamma-1 and phosphorylation of phosphatidylinositol 3-kinase are blocked in the presence of K252a. The detection of the NT-3-mediated early signal transduction events demonstrates that TrkC receptor exhibits NT-3-mediated intracellular response in oligodendroglial cells.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8776670     DOI: 10.1002/(SICI)1097-4547(19960601)44:5<490::AID-JNR9>3.0.CO;2-A

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  7 in total

1.  Combination of growth factors enhances remyelination in a cuprizone-induced demyelination mouse model.

Authors:  Shalini Kumar; Juan Carlos Biancotti; Masahiro Yamaguchi; Jean de Vellis
Journal:  Neurochem Res       Date:  2006-12-21       Impact factor: 3.996

Review 2.  Pharmacological approaches to intervention in hypomyelinating and demyelinating white matter pathology.

Authors:  Li-Jin Chew; Cynthia A DeBoy
Journal:  Neuropharmacology       Date:  2015-06-24       Impact factor: 5.250

3.  Differential expression of brain-derived neurotrophic factor, neurotrophin-3, and neurotrophin-4/5 in the adult rat spinal cord: regulation by the glutamate receptor agonist kainic acid.

Authors:  I A Scarisbrick; P J Isackson; A J Windebank
Journal:  J Neurosci       Date:  1999-09-15       Impact factor: 6.167

4.  Neurotrophin-3 and brain-derived neurotrophic factor induce oligodendrocyte proliferation and myelination of regenerating axons in the contused adult rat spinal cord.

Authors:  D M McTigue; P J Horner; B T Stokes; F H Gage
Journal:  J Neurosci       Date:  1998-07-15       Impact factor: 6.167

5.  Relation between variants in the neurotrophin receptor gene, NTRK3, and white matter integrity in healthy young adults.

Authors:  Meredith N Braskie; Omid Kohannim; Neda Jahanshad; Ming-Chang Chiang; Marina Barysheva; Arthur W Toga; John M Ringman; Grant W Montgomery; Katie L McMahon; Greig I de Zubicaray; Nicholas G Martin; Margaret J Wright; Paul M Thompson
Journal:  Neuroimage       Date:  2013-05-30       Impact factor: 6.556

6.  Brain-derived neurotrophic factor effects on oligodendrocyte progenitors of the basal forebrain are mediated through trkB and the MAP kinase pathway.

Authors:  Ashlee Van't Veer; Yangzhou Du; Tanya Z Fischer; Deborah R Boetig; Melissa R Wood; Cheryl F Dreyfus
Journal:  J Neurosci Res       Date:  2009-01       Impact factor: 4.164

7.  An agent for optical imaging of TrkC-expressing, breast cancer.

Authors:  Anyanee Kamkaew; Feng Li; Zheng Li; Kevin Burgess
Journal:  Medchemcomm       Date:  2017-09-14       Impact factor: 3.597

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.